Compendium of Cancer Genome Aberrations

Changes

BRST5:Volunteer Assignments and Opportunities (view source)

Revision as of 08:51, 9 April 2024

1,073 bytes added ,  9 April
no edit summary
Line 19: Line 19:  
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
−
|CHAPTER 2 (EPITHELIAL TUMOURS OF THE )
+
|CHAPTER 2 (EPITHELIAL TUMOURS OF THE BREAST)
−
|Disease
+
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
 
|Usual Ductal Hyperplasia
 
|Usual Ductal Hyperplasia
 
|Disease
 
|Disease
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 305: Line 320:  
|
 
|
 
|-
 
|-
−
|Acinic Cell Carcinoma||Disease||
+
|[[BRST5:Acinic Cell Carcinoma|Acinic Cell Carcinoma]]||Disease||Patricija Zot
−
|
+
|2/28/2024
−
|
  −
|
   
|
 
|
 +
|PENDING
 
|
 
|
 +
|Katherine Geiersbach
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|[[Adenoid Cystic Carcinoma]]||Disease||Katherine Geiersbach / Jun Liao
+
|[[BRST5:Adenoid Cystic Carcinoma|Adenoid Cystic Carcinoma]]||Disease||Katherine Geiersbach / Jun Liao
 
|10/12/02022
 
|10/12/02022
 
|11/11/2023
 
|11/11/2023
Line 323: Line 338:  
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|[[Secretory Carcinoma]]||Disease||Hui Chen / Morteza Seifi
+
|[[BRST5:Secretory Carcinoma|Secretory Carcinoma]]||Disease||Hui Chen / Morteza Seifi
 
|10/12/2022
 
|10/12/2022
 
|11/11/2023
 
|11/11/2023
−
|PENDING
+
|COMPLETE
 
|
 
|
 
|Katherine Geiersbach
 
|Katherine Geiersbach
Line 350: Line 365:  
|
 
|
 
|-
 
|-
−
|[[Tall Cell Carcinoma with Reversed Polarity]]||Disease||H. Evin Gulbahce
+
|[[BRST5:Tall Cell Carcinoma with Reversed Polarity|Tall Cell Carcinoma with Reversed Polarity]]||Disease||H. Evin Gulbahce
 
|8/11/2023
 
|8/11/2023
 
|10/11/2023
 
|10/11/2023
Line 376: Line 391:  
|
 
|
 
|
 
|
 +
|-
 +
|CHAPTER 3 (FIBROEPITHELIAL TUMOURS AND HAMARTOMAS OF THE BREAST)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|Hamartoma||Disease||
 
|Hamartoma||Disease||
Line 386: Line 421:  
|
 
|
 
|-
 
|-
−
|[[Fibroadenoma]]||Disease||H. Evin Gulbahce / Patricija Zot
+
|[[BRST5:Fibroadenoma|Fibroadenoma]]||Disease||H. Evin Gulbahce / Patricija Zot
 
|8/11/2023
 
|8/11/2023
 
|11/11/2023
 
|11/11/2023
Line 395: Line 430:  
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|[[Phyllodes Tumour]]||Disease||Emilie Lalonde / H. Evin Gulbahce /Katherine Geiersbach
+
|[[BRST5:Phyllodes Tumour|Phyllodes Tumour]]||Disease||Emilie Lalonde / H. Evin Gulbahce /Katherine Geiersbach
 
|8/11/2023
 
|8/11/2023
 
|11/11/2023
 
|11/11/2023
Line 403: Line 438:  
|
 
|
 
|2021 template added
 
|2021 template added
 +
|-
 +
|CHAPTER 4 (TUMOURS OF THE NIPPLE)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|Syringomatous Tumour||Disease||
 
|Syringomatous Tumour||Disease||
Line 430: Line 485:  
|
 
|
 
|
 
|
 +
|-
 +
|CHAPTER 5 (MESENCHYMAL TUMOURS OF THE BREAST)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|Haemangioma||Disease||
 
|Haemangioma||Disease||
Line 503: Line 578:  
|
 
|
 
|-
 
|-
−
|[[Inflammatory Myofibroblastic Tumour]]||Disease||Yajuan Liu
+
|[[BRST5:Inflammatory Myofibroblastic Tumour|Inflammatory Myofibroblastic Tumour]]||Disease||Yajuan Liu
 
|8/11/2023
 
|8/11/2023
 
|11/11/2023
 
|11/11/2023
Line 592: Line 667:  
|
 
|
 
|
 
|
 +
|-
 +
|CHAPTER 6 (HAEMATOLYMPHOID TUMOURS OF THE BREAST)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||
 
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||
Line 637: Line 732:  
|
 
|
 
|
 
|
 +
|-
 +
|CHAPTER 7 (TUMOURS OF THE MALE BREAST)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|Gynaecomastia||Disease||
 
|Gynaecomastia||Disease||
Line 673: Line 788:  
|
 
|
 
|
 
|
 +
|-
 +
|CHAPTER 8 (GENETIC TUMOUR SYNDROMES OF THE BREAST)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome||Disease||Constance Albarracin / Katherine Geiersbach
 
|BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome||Disease||Constance Albarracin / Katherine Geiersbach
Line 755: Line 890:  
|NOT YET CREATED - See page "[[Neurofibromatosis Type 1 (NF1)]]" in GTS5 book. Will later add breast book link redirecting to this GTS5 book page (need to correlate with related volunteer page - [[GTS5:Volunteer Assignments and Opportunities]]).
 
|NOT YET CREATED - See page "[[Neurofibromatosis Type 1 (NF1)]]" in GTS5 book. Will later add breast book link redirecting to this GTS5 book page (need to correlate with related volunteer page - [[GTS5:Volunteer Assignments and Opportunities]]).
 
|-
 
|-
−
|[[Polygenic Component of Breast Cancer Susceptibility]]
+
|[[BRST5:Polygenic Component of Breast Cancer Susceptibility|Polygenic Component of Breast Cancer Susceptibility]]
 
|Disease
 
|Disease
 
|
 
|
Retrieved from "https://ccga.io/index.php/Special:MobileDiff/14217...14402"